Levy Richard S
SEC-identified person · CIK 1454983 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Synta Pharmaceuticals Corp SNTA | Director | filed 2016–2026 |
| Protara Therapeutics, Inc. TARA | Director | filed 2020–2026 |
| Kiniksa Pharmaceuticals, Ltd. KNSA | Director | filed 2019–2026 |
| Kodiak Sciences Inc. KOD | Director | filed 2018–2025 |
| Constellation Pharmaceuticals INC CNST | Director | filed 2020–2021 |
| Neurogene Inc. NLTX | Director | filed 2017–2017 |
| Incyte Corp INCY | EVP, Chief Drug Dev&Medical Of | filed 2009–2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.